You are here

research

400x400_joan_bertran.png
10.03.2021

Joan Bertran

Founder and CEO

Joan Bertran is a textile engineer, specializing in technical fabrics. In this field, he has worked in the aeronautics, automobile, renewable energy and, most recently, biomedical sectors. He has been director of operations and a member of the executive board at international textile companies. He has a master in Operations Management and an MBA. When a friend’s daughter died of cancer, he was inspired to become an entrepreneur in biotechnology. 

BDebate Brain Health for Life
18.12.2020

One in four people in the world have a psychiatric or neurological condition. The course Brain Health for Life. Preventing Brain-Related Disability, promoted by EIT Health and organized by Biocat, the ”la Caixa” Foundation and Institut Guttmann, raised awareness of the latest studies on brain health with some of the top researchers in the world.

Jordi Naval i Judit Anido
28.09.2020

Venture capital with international participation is up 67.1%, becoming the main driving force behind increased investment, according to BioRegion of Catalonia Life Sciences and Healthcare Outlook 2020 - Challenges Ahead, presented by Biocat and CataloniaBio & HealthTech.

Conquering Cancer: Mission possible
17.07.2020

The EC is opening up participative processes in Europe to define an ambitious objective for 2030: to save more than 3,000,000 lives

23.06.2020

Covid-19 continues to be a trending topic, but research in other fields is regaining prominence

17.12.2019

Corporate operations and science publications round out December’s headlines in the ecosystem

Catalonia, among the top 10 in Europe in clinical trials

Catalonia is among the top 10 countries in Europe in terms of participation in clinical trials and among the top 20 in the world; looking at oncology alone, it is in the European Top 5 and the global Top 10. This November, Barcelona hosted the international Clinical Trials Europe event: a great time to look back over the factors that have made the BioRegion a benchmark in attracting trials from all the major pharmaceutical companies in the world, and also at the future challenges this sector is facing.